Discover
GLMD
Galmed Pharmaceuticals Ltd.
0.65
2 x 0.50
2 x 0.81
bid
ask
+
0.09
16.45%
2 @ 04:00 PM
0.59 -0.05 (8.34%)
| Ytd | -13.74% | |
| 1y | -63.61% |
0.55
day range
0.72
0.41
52 week range
2.34
| Open | 0.55 | Prev Close | 0.56 | Low | 0.55 | High | 0.72 | Mkt Cap | 4.98M |
| Vol | 431.07K | Avg Vol | 3.47M | EPS | -2.39 | P/E | N/A | Forward P/E | -2.94 |
| Beta | 0.80 | Short Ratio | 0.27 | Inst. Own | 0.48% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 09-01 | 50-d Avg | 0.61 | 200-d Avg | 0.86 | 1yr Est | 12.00 |
GLMD News
benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Curis (NASDAQ:CRIS) stock rose 9.0% to $0.46 during Wednesday's after-market session. T
benzinga.com
Galmed Pharmaceuticals Has Received A Notice Of Allowance For A U.S. Patent Titled "TREATMENT FOR FI
https://x.com/PatentGrants/status/2072409116040130916 https://patentcenter.uspto.gov/applications/17
benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers Quoin Pharmaceuticals (NASDAQ:QNRX) shares rose 40.3% to $4.56 during Tuesday's after-m
benzinga.com
Galmed Agrees With Acquisition Target Colospan To Increase The Cash Portion Of Purchase Price By $80
Colospan Ltd. ("Colospan") provides Galmed Pharmaceuticals Ltd. ("Galmed") (NASDAQ:G
benzinga.com
Galmed Pharmaceuticals Signs Agreement To Acquire Medical Device Firm Colospan For $2.5M In Cash, $2
Galmed Pharmaceuticals Ltd. ("Galmed") (NASDAQ:GLMD) today announced that it has entered int
benzinga.com
UK's MHRA Says Resmetirom (Rezdiffra) Authorized To Treat Metabolic Dysfunction-Associated Steatohep
https://www.gov.uk/government/news/resmetirom-rezdiffra-authorised-to-treat-metabolic-dysfunction-as
benzinga.com
Galmed Reports Preclinical Results for Heart Disease Drug Combination, Study Identifies New Pathway
Tissue Dynamics Ltd. and Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) ("Galmed" or the "Com